Avior Wealth Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-220
| Closed | -$7.02K | – | 822 |
|
|
2024
Q4 | $7.02K | Buy |
+220
| New | +$7.02K | ﹤0.01% | 1746 |
|
|
2024
Q2 | – | Sell |
-401
| Closed | -$23.6K | – | 2339 |
|
|
2024
Q1 | $23.6K | Buy |
+401
| New | +$23.6K | ﹤0.01% | 1531 |
|
|
2023
Q4 | – | Sell |
-3,806
| Closed | -$145K | – | 1529 |
|
|
2023
Q3 | $145K | Buy |
3,806
+1,039
| +38% | +$39.5K | 0.01% | 575 |
|
|
2023
Q2 | $252K | Sell |
2,767
-1,028
| -27% | -$93.7K | 0.02% | 478 |
|
|
2023
Q1 | $250K | Buy |
3,795
+413
| +12% | +$27.2K | 0.02% | 483 |
|
|
2022
Q4 | $175K | Buy |
+3,382
| New | +$175K | 0.01% | 484 |
|